This process results in the release of soluble factors from the bone matrix including insulin-like growth factor 1 (IGF1) and CXCL12, which stimulate activation of the PI3K-AKT pathway thereby enhancing BC cell proliferation and survival in the bone [117,118]. This evidence concerns the gene AKT1 and breast cancer.